Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Mj biopharm pvt. Ltd, 113, Jolly Makers Chambers No.2, Nariman Point, Mumbai 400 021 - The Pharma Times | Pharma & Health Care News Portal
Categories: Manufacturers (D)

Mj biopharm pvt. Ltd, 113, Jolly Makers Chambers No.2, Nariman Point, Mumbai 400 021

Company Name : Mj biopharm pvt. Ltd

Address : 113, Jolly Makers Chambers No.2, Nariman Point, Mumbai 400 021

Tel No: 022 22020644

Email : mjgroup@mj-india.com

Website : http://www.mjbiopharm.com/

Company Profile

MJ Biopharm Pvt. Ltd. is the flagship company of the MJ Group, formed to facilitate Quality Healthcare through its highly specialized range of pharmaceutical products / formulations in the domestic and export market. The company excels in animal and human rDNA Insulin and other dosage forms such as tablets, capsules, cephalosporin injectables, other injectable ampoules and vials in different specialty segments such as Diabetology, Cardiology, NSAID, Anti-inflammatory, Anti-biotics etc.

Prime among these is the human rDNA Insulin formulation, manufactured in collaboration with Akzo Nobel – the Dutch multi-national giant. MJ Biopharm, along with its London based associate company – Marvel Lifescience, is aiming for a higher stake in the global pharmaceutical market, especially in human rDNA Insulin formulations. The company markets the insulin formulation under brand name “Biosulin”.

MJ Biopharm’s products are registered in over twenty countries and are in the process of registration in more than 60 countries worldwide.

The focus in adopting the BEST business practices is to provide the finest healthcare brands, to enhance business performance and to emerge as a leading / dominant global player in the dynamic and competitive pharmaceutical industry.

The Pharma Times News Bureau

Recent Posts

Gleneagles Hospital Mumbai Introduces Pediatric Bone Marrow Transplant (BMT) Facility

New Delhi, May 17, 2024: In response to the growing need for specialized pediatric care,…

19 hours ago

Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT);

Achieves significant advancement in Cancer Treatment to Enhance Quality of Life  As per the National…

2 days ago

Two Complex Robotic Kidney Transplant Surgeries Successfully Performed at Fortis Hospital Bannerghatta Road

-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…

3 days ago

On International Nurses Day, American Oncology Institute (AOI) launches #TheExtraordinaryCareGiver Campaign as Tribute to Oncology Nurses

Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…

4 days ago

SOCC Unveils A New Era In Paediatric Care: Second Opinion Online Consultations For Children

Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…

7 days ago

India’s First Lady Surgeon Trained in Robotic Breast Surgery Performs Karnataka’s 1st Robotic Nipple Sparing Mastectomy

Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…

1 week ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420